About Mr Chatzizacharias

Mr N. Chatzizacharias is a Consultant Hepatopancreatobiliary (HPB) and Liver Transplant Surgeon in Queen Elizabeth Hospital, Birmingham. He graduated from the University of Athens, Greece, Medical School and holds a PhD from the same institution. Alongside his NHS commitments, he holds an Honorary contract with the University of Birmingham School of Medical and Dental Science as an Associate Clinical Professor. He is a member of various national and international societies, including the European-African and International HPB Associations.

Mr Chatzizacharias completed his Junior Surgical training in Oxford, where he was introduced to HPB and Transplant Surgery. He then moved to an academic Higher Surgical Training post in the University of Cambridge. After completing his surgical training in the Eastern Deanery, he secured a competitive and prestigious HPB Fellowship in the Medical College of Wisconsin, USA (ASGME accredited). Mr Chatzizacharias returned in the UK in 2017 and has been a consultant since in the HPB and Liver Transplant Unit in Queen Elizabeth Hospital. His clinical expertise includes treatment of all conditions of the liver, pancreas and biliary tract, benign and malignant. He performs open and minimal invasive surgical procedures (trained both in laparoscopic and robotic surgery). His area of specialist interest is the management of locally advanced pancreatic cancer. Since his appointment, he has developed and is leading the locally advanced pancreatic cancer programme of Queen Elizabeth and referring Hospitals. With more than 100 patients managed yearly, this is the largest programme in the UK and one of the largest in the world. The multidisciplinary care consists of systemic treatment, radiotherapy and surgery, including some of the most complex venous and arterial resections.

Mr Chatzizacharias holds a PhD in pancreatic cancer. He has authored a number of peer reviewed publications and has numerous presentations in national and international meetings. He is the principal investigator in the DISSECT trial (investigating the role of periadventitial dissection in achieving improved surgical margins during surgery for resectable pancreatic cancer), as well as various other prospective and retrospective studies. He is an educational supervisor of final year medical students and a supervisor in the MSci intercalated programme of the University of Birmingham Medical School.